BIO-TECHNE Corp Share-based Payment Arrangement, Expense
BIO-TECHNE Corp (TECH) reported Share-based Payment Arrangement, Expense of $40.28 million for the 12-month period ending 2024-06-30, per its 10-K filed 2024-08-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-08-22
- BIO-TECHNE Corp share-based payment arrangement, expense for the quarter ending 2020-09-30 was $13.33M, a 51.51% increase year-over-year.
- BIO-TECHNE Corp share-based payment arrangement, expense for the quarter ending 2019-09-30 was $8.80M, a 23.91% decline year-over-year.
- BIO-TECHNE Corp share-based payment arrangement, expense for the quarter ending 2018-09-30 was $11.56M.
- BIO-TECHNE Corp share-based payment arrangement, expense for the quarter ending 2011-09-30 was $290.00K, a 113.24% increase year-over-year.
- BIO-TECHNE Corp share-based payment arrangement, expense for fiscal 2024 was $40.28M, a 2.28% decline from fiscal 2023.
- BIO-TECHNE Corp share-based payment arrangement, expense for fiscal 2023 was $41.22M, a 11.17% decline from fiscal 2022.
- BIO-TECHNE Corp share-based payment arrangement, expense for fiscal 2022 was $46.40M, a 10.50% decline from fiscal 2021.
- BIO-TECHNE Corp share-based payment arrangement, expense for fiscal 2021 was $51.85M, a 51.32% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|
| 2024-06-30 | $40.28M 10-K · filed 2024-08-22 | |
| 2023-06-30 | $41.22M 10-K · filed 2024-08-22 | |
| 2022-06-30 | $46.40M 10-K · filed 2024-08-22 | |
| 2021-06-30 | $51.85M 10-K · filed 2023-08-23 | |
| 2020-09-30 | $13.33M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $34.26M 10-K · filed 2022-08-24 | |
| 2019-09-30 | $8.80M 10-Q · filed 2020-11-09 | |
| 2018-09-30 | $11.56M 10-Q · filed 2019-11-06 | |
| 2011-09-30 | $290.00K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $1.10M 10-K · filed 2011-08-29 | |
| 2010-09-30 | $136.00K 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $1.10M 10-K · filed 2011-08-29 | |
| 2009-06-30 | $1.50M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |